Sunday, April 17, 2016

US widens use of Boehringer's lung cancer drug Gilotrif

… of EGFR mutation-positive non-small cell lung cancer.
 
Approval for squamous cell carcinoma … : delay in the progression of lung cancer, reducing the risk by 18 …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)